Back
Beam Therapeutics Stock Price Chart
Sponsored
BEAM
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Buy
64
BEAM
Beam Therapeutics
Last Price:
27.02
Seasonality Move:
54.38%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing buying pressure, which is a positive indicator for future bullish movement.
Beam Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.43 | Buy |
20-day SMA: | 23.96 | Buy |
50-day SMA: | 24.28 | Buy |
200-day SMA: | 26.78 | Buy |
8-day EMA: | 25 | Buy |
20-day EMA: | 24.2 | Buy |
50-day EMA: | 24.37 | Buy |
200-day EMA: | 26.06 | Buy |
Beam Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.37 | Buy |
Relative Strength Index (14 RSI): | 63.81 | Buy |
Chaikin Money Flow: | 789902 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.12 - 25.54) | Buy |
Bollinger Bands (100): | (22.76 - 27.44) | Buy |
Beam Therapeutics Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Beam Therapeutics Stock
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 27.06 while BEAM 8-day simple moving average is 24.43, which is a Buy signal.
- The stock price of BEAM is 27.06 while Beam Therapeutics 20-day SMA is 23.96, which makes it a Buy.
- Beam Therapeutics 50-day simple moving average is 24.28 while BEAM share price is 27.06, making it a Buy technically.
- BEAM stock price is 27.06 and Beam Therapeutics 200-day simple moving average is 26.78, creating a Buy signal.
BEAM Technical Analysis vs Fundamental Analysis
Buy
64
Beam Therapeutics (BEAM)
is a Buy
Is Beam Therapeutics a Buy or a Sell?
-
Beam Therapeutics stock is rated a Buy
The current Beam Therapeutics [BEAM] share price is $27.06. The Score for BEAM is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Beam Therapeutics Stock Info
Market Cap:
2.24B
Price in USD:
27.06
Share Volume:
1.27M
Beam Therapeutics 52-Week Range
52-Week High:
49.50
52-Week Low:
18.85
Buy
64
Beam Therapeutics (BEAM)
is a Buy
Beam Therapeutics Share Price Forecast
-
What is the Beam Therapeutics stock price today?
The Beam Therapeutics stock price is 27.06 USD today. -
Will BEAM stock go up or go down?
Beam Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Beam Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics is not overvalued.
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 27.06 while BEAM 8-day exponential moving average is 25.00, which is a Buy signal.
- The stock price of BEAM is 27.06 while Beam Therapeutics 20-day EMA is 24.20, which makes it a Buy.
- Beam Therapeutics 50-day exponential moving average is 24.37 while BEAM share price is 27.06, making it a Buy technically.
- BEAM stock price is 27.06 and Beam Therapeutics 200-day simple moving average is 26.06, creating a Buy signal.
Fundamental Analysis of Beam Therapeutics
Is Beam Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.58 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Beam Therapeutics
Should I short Beam Therapeutics stock?
- BEAM Moving Average Covergence Divergence (MACD) indicator is 0.37, suggesting Beam Therapeutics is a Buy
- Beam Therapeutics Relative Strength Index (RSI) is 63.81, which suggest Beam Therapeutics is overbought
- The Bollinger Bands (25) for Beam Therapeutics is (22.12 - 25.54), which suggest Beam Therapeutics is a Buy
- The Bollinger Bands (100) for Beam Therapeutics is (22.76 - 27.44), which suggest Beam Therapeutics is a Buy
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.